Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid
- 30 April 2002
- journal article
- research article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 175 (1) , 45-53
- https://doi.org/10.1046/j.1365-201x.2002.00962.x
Abstract
Kynurenic acid (KYNA) is an antagonist of ionotropic glutamate receptors, preferentially blocking the glycine-site of the N-methyl-D-aspartate (NMDA) receptor. In the present electrophysiological study, the firing pattern of dopamine (DA) neurones of rat ventral tegmental area (VTA) was investigated following pharmacologically elevated endogenous levels of KYNA by means of an inhibitor of kynurenine 3-hydroxylase (PNU 156561A). Pre-treatment with PNU 156561A (40 mg kg–1, i.v., 5–9 h) caused a threefold increase in endogenous KYNA in whole brain levels and also evoked a significant increase in firing rate and bursting activity of VTA DA neurones. Administration of D-cycloserine (2–128 mg kg–1, i.v.), a partial agonist at the glycine-site of the NMDA-receptor, was found to reverse the increase in firing rate and bursting activity as induced by elevated concentrations of KYNA. The electrophysiological effects of elevated KYNA levels were in all essential mimicked by administration of the NMDA-receptor antagonist MK 801 (0.05–1.6 mg kg–1, i.v.). Thus, the effects of elevated endogenous brain KYNA observed in the present study are likely to be carried out by NMDA receptor antagonism. In conclusion, this study shows that an increase in endogenous KYNA levels produces significant actions on the tonic afferent control of the firing pattern of VTA DA neurones. Given the psychotomimetic effects of NMDA-receptor antagonists, e.g. phencyclidine and ketamine, the state of hyperactivity of mesocorticolimbic DA system induced by elevated levels of KYNA may represent a pathophysiological condition analogous to that seen in schizophrenic patients.Keywords
This publication has 58 references indexed in Scilit:
- Presynaptic inhibition preferentially reduces the NMDA receptor-mediated component of transmission in rat midbrain dopamine neuronsBritish Journal of Pharmacology, 1999
- Activation of nigral dopamine neurons by the selective GABA B -receptor antagonist SCH 50911Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free SchizophrenicsNeuropsychopharmacology, 1997
- NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy VolunteersNeuropsychopharmacology, 1996
- Pharmacologically induced cessation of burst activity in nigral dopamine neurons: Significance for the terminal dopamine effluxSynapse, 1994
- Kynurenic Acid: A Potential Pathogen in Brain DisordersaAnnals of the New York Academy of Sciences, 1992
- Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological dataBrain Research, 1990
- Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutininJournal of Comparative Neurology, 1989
- Mesocorticolimbic Dopamine Systems and RewardAnnals of the New York Academy of Sciences, 1988
- Presence of Kynurenic Acid in the Mammalian BrainJournal of Neurochemistry, 1988